Not logged in.png)
Share.png)
SaveSocioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study
Yokoyama, Kazuki; Honda, Kazunori; Matsumoto, Kazuko; Ando, Yayoi; Ito, Munehiro; Goto, Rei; Shinno, Yuki; Shimoi, Tatsunori; Suzuki, Tatsuya; Yoshioka, Takashi; Ishiki, Hiroto Share Save Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case seriesNakamura, Tomoaki; Yoshida, Tatsuya; Yoshida, Akihiko; Tateishi, Akiko; Shinno, Yuki; Matsumoto, Yuji; Mizutani, Tomonori; Okuma, Yusuke; Horinouchi, Hidehito; Yamamoto, Noboru; Yatabe, Yasushi; Goto, Yasushi Share Save A series of natural language processing for predicting tumor response evaluation and survival curve from electronic health recordsTakeuchi, Toshiki; Horinouchi, Hidehito; Takasawa, Ken; Mukai, Masami; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Yamamoto, Noboru; Ohe, Yuichiro; Miyake, Mototaka; Watanabe, Hirokazu; Kusumoto, Masahiko; Aoki, Takashi; Nishimura, Kunihiro; Hamamoto, Ryuji Share Save EGFR-Mutated Lung Adenocarcinoma With Li-Fraumeni Syndrome: The Imperative for Germline Testing in Patients With a Family History, a Case ReportFujii, Hiroyuki; Okuma, Yusuke; Hirata, Makoto; Shinno, Yuki; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Share Save WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancerYamamoto, Gaku; Tanaka, Kosuke; Kamata, Ryo; Saito, Hitoshi; Yamamori-Morita, Tomoko; Nakao, Takehiro; Liu, Jie; Mori, Shunta; Yagishita, Shigehiro; Hamada, Akinobu; Shinno, Yuki; Yoshida, Tatsuya; Horinouchi, Hidehito; Ohe, Yuichiro; Watanabe, Shun-Ichi; Yatabe, Yasushi; Kitai, Hidenori; Konno, Satoshi; Kobayashi, Susumu S.; Ohashi, Akihiro Share Save Multiomics analysis of malignant pleural mesothelioma and the effect of immune checkpoint inhibitorsTateishi, A. T.; Yoshida, T.; Shiraish, K.; Torasawa, M.; Igawa, Y.; Masuda, K.; Shinno, Y.; Okuma, Y.; Goto, Y.; Horinouchi, H.; Yamamoto, N.; Kohno, T.; Ohe, Y. Share Save Clinical significance of inter-assay discrepancy in PD-L1 expression evaluation for the efficacy of pembrolizumab in advanced NSCLC patients with high PD-L1 expressionMiyakoshi, Jun; Kashima, Jumpei; Shirasawa, Masayuki; Torasawa, Masahiro; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Shiraishi, Kouya; Kohno, Takashi; Yamamoto, Noboru; Yatabe, Yasushi; Ohe, Yuichiro Share Save Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR MutationsTakeyasu, Yuki; Yoshida, Tatsuya; Masuda, Ken; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Share Save Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer (vol 129, 2034, 2023)Shirasawa, Masayuki; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Yagishita, Shigehiro; Imabayashi, Tatsuya; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yotsukura, Masaya; Yoshida, Yukihiro; Nakagawa, Kazuo; Naoki, Katsuhiko; Tsuchida, Takaaki; Hamamoto, Ryuji; Yamamoto, Noboru; Motoi, Noriko; Kohno, Takashi; Watanabe, Shun-ichi; Ohe, Yuichiro Share Save Impact of tumor genomic alterations on development of cancer cachexia in patients with advanced non-small cell lung cancerFujii, Hiroyuki; Yoshida, Tatsuya; Shirasawa, Masayuki; Fujimoto, Kazushi; Mizuno, Takaaki; Sunami, Kuniko; Koyama, Takafumi; Motoi, Noriko; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Share Save Influence of durvalumab consolidation on pneumonitis after chemoradiotherapy for unresectable non-small cell lung cancerMurata, Saori; Horinouchi, Hidehito; Morishita, Momoko; Kaku, Sawako; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Yamamoto, Noboru; Okuma, Kae; Kusumoto, Masahiko; Ohe, Yuichiro Share Save Impact of sarcopenia on the outcome of patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy followed by durvalumabTamura, K.; Horinouchi, H.; Miyake, M.; Masuda, K.; Shinno, Y.; Okuma, Y.; Yoshida, T.; Goto, Y.; Yamamoto, N.; Ohe, Y. Share Save Steroid-resistant and refractory irAEs requiring additional immunosuppressants to steroids in advanced NSCLC patientsShimoda, Yukiko; Yoshida, Tatsuya; Torasawa, Masahiro; Tateishi, Akiko; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Share Save Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinibUehara, Yuji; Yoshida, Tatsuya; Takeyasu, Yuki; Tateichi, Akiko; Torasawa, Masahiro; Masuda, Ken; Shinno, Yuki; Matsumoto, Yuji; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Share Save Early evidence of efficacy in patients (pts) with non-small cell lung cancer (NSCLC) with HER2 exon20 insertion (ex20ins) mutations treated in a phase I study with BAY 2927088Loong, H. H. F.; Daniele, G.; Yang, T-Y.; Leal, T. A.; Goto, K.; Shinno, Y.; Nishino, K.; Sakamoto, T.; Felip, E.; Ruffinelli, J. C.; Gallot, N.; Wang, Z.; Chen, C.; Brennan, B.; Pu, S-F.; Kornacker, M.; Grassi, P.; Le, X.; Tan, D. S. W.; Goh, B-C. Share Save Association between the adverse events and serum concentrations of lorlatinib in patients with advanced ALKpositive lung cancerShimoda, Y.; Yoshida, T.; Makihara, R. A.; Torasawa, M.; Tateishi, A.; Matsumoto, Y.; Shinno, Y.; Okuma, Y.; Goto, Y.; Horinouchi, H.; Yamamoto, N.; Ohe, Y. Share Save Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancerShirasawa, Masayuki; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Yagishita, Shigehiro; Imabayashi, Tatsuya; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yotsukura, Masaya; Yoshida, Yukihiro; Nakagawa, Kazuo; Naoki, Katsuhiko; Tsuchida, Takaaki; Hamamoto, Ryuji; Yamamoto, Noboru; Motoi, Noriko; Kohno, Takashi; Watanabe, Shun-ichi; Ohe, Yuichiro Share Save Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastasesTamura, K.; Yoshida, T.; Masuda, K.; Matsumoto, Y.; Shinno, Y.; Okuma, Y.; Goto, Y.; Horinouchi, H.; Yamamoto, N.; Ohe, Y. Share Save Concordance between cryobiopsy and forceps biopsy specimens in assessment of immunohistochemistry staining for non-small cell lung carcinomaNishimatsu, Kanako; Matsumoto, Yuji; Kashima, Jumpei; Imabayashi, Tatsuya; Uchimura, Keigo; Furuse, Hideaki; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Tsuchida, Takaaki; Ohe, Yuichiro; Yatabe, Yasushi Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
